BioSmart바이오스마트
038460 · KOSDAQ · ₩038460 · 바이오스마트
₩2,460▲ ₩40 (1.65%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 15.5% | 17.7% | 17.0% | 17.3% | 19.6% | 36.2% |
| Operating margin | 5.0% | 4.7% | 4.2% | 2.2% | 2.6% | 4.2% |
| Net margin | 2.4% | 1.9% | 0.0% | 3.9% | 0.2% | 0.7% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +16.6% | −0.3% | +6.2% | +16.4% | +107.1% | — |
| Operating income growth | +23.9% | +11.5% | +100.6% | −0.6% | +26.4% | — |
| Net income growth | +49.7% | +6,984.2% | −99.3% | +2,382.6% | −48.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 9.2% | 6.6% | 0.1% | 17.2% | 0.7% | 1.4% |
| Return on assets | 4.2% | 3.1% | 0.4% | 6.5% | −0.5% | 0.3% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 74.9% | 65.1% | 68.0% | 113.8% | 157.0% | 146.5% |
| Net debt to equity | 21.4% | 22.3% | 23.8% | 43.7% | 63.8% | 58.9% |
| Current ratio | 143.7% | 170.9% | 168.7% | 112.5% | 98.8% | 130.1% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: BioSmart / 바이오스마트 / 038460 / KRX:038460
Source: KRX statistical information